Of the activating RAF1-fusion melanomas, 98% (n = 39) were wild type for BRAF, NRAS, and NF1 genomic alterations (triple wild type) vs. 26% (n = 1843/7079) of the melanoma cohort without RAF1 fusion (p < 0.0001, Fisher’s exact test). This evidence concerns the gene BRAF and melanoma.